Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: Mar 2, 2023
Date Accepted: Mar 2, 2023

The final, peer-reviewed published version of this preprint can be found here:

Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”

Mabuka T, Naidoo N, Ncube N, Yiga T, Ross M, Kurehwa K, Nare M, Silaji A, Ndemera T, Lemeke T, Taiwo R, Macharia W, Sithole M

Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”

JMIRx Med 2023;4:e46944

DOI: 10.2196/46944

PMCID: 10588734

Authors’ Responses to Peer Review Reports

  • Thabo Mabuka; 
  • Natalie Naidoo; 
  • Nesisa Ncube; 
  • Thabo Yiga; 
  • Michael Ross; 
  • Kuzivakwashe Kurehwa; 
  • Mothabisi Nare; 
  • Andrea Silaji; 
  • Tinashe Ndemera; 
  • Tlaleng Lemeke; 
  • Ridwan Taiwo; 
  • Willie Macharia; 
  • Mthokozisi Sithole

ABSTRACT

This is the authors’ responses to peer review reports related to MS ID34598


 Citation

Please cite as:

Mabuka T, Naidoo N, Ncube N, Yiga T, Ross M, Kurehwa K, Nare M, Silaji A, Ndemera T, Lemeke T, Taiwo R, Macharia W, Sithole M

Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”

JMIRx Med 2023;4:e46944

DOI: 10.2196/46944

PMCID: 10588734

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.